Showing results (1651-1660 of 1,963) with videos related to

Sort By:
Pageof 197
RMD Open|September 8, 2021
Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine SurveySebastian Eduardo Sattui, Jean W Liew, Kevin Kennedy, et al.
RMD Open|September 3, 2021
Patient and healthcare professional eHealth literacy and needs for systemic sclerosis support: a mixed methods studyAgnes Kocher, Michael Simon, Andrew A Dwyer, et al.
RMD Open|August 22, 2022
Analysis of risk factors of mortality in rheumatoid arthritis patients with interstitial lung disease: a nationwide, population-based cohort study in TaiwanKooi-Heng Ng, Der-Yuan Chen, Ching-Heng Lin, et al.
RMD Open|May 20, 2021
Guselkumab induces robust reduction in acute phase proteins and type 17 effector cytokines in active psoriatic arthritis: results from phase 3 trialsKristen Sweet, Qingxuan Song, Matthew J Loza, et al.
RMD Open|August 8, 2022
Gender equity in academic rheumatology, current status and potential for improvement: a cross-sectional study to inform an EULAR task forcePavel V Ovseiko, Laure Gossec, Laura Andreoli, et al.
RMD Open|August 19, 2022
Unmet need for patient involvement in rheumatology registries and observational studies: a mixed methods studyPaul Studenic, Mandeep Sekhon, Loreto Carmona, et al.
RMD Open|May 8, 2021
Physical activity in patients with rheumatoid arthritis - an agile lifelong behaviour: a qualitative meta-synthesisEmma Swärdh, Christina Opava, Nina Brodin
RMD Open|May 25, 2021
Short-term glucocorticoids reduce risk of chronic NSAID and analgesic use in early methotrexate-treated rheumatoid arthritis patients with favourable prognosis: subanalysis of the CareRA randomised controlled trialSofia Pazmino, Annelies Boonen, Diederik De Cock, et al.
RMD Open|May 13, 2020
Assessing the sensitivity to change of the OMERACT ultrasound structural gout lesions during urate-lowering therapySara Nysom Christiansen, Mikkel Østergaard, Ole Slot, et al.
RMD Open|May 7, 2020
Long-term safety, immunogenicity and efficacy comparing FKB327 with the adalimumab reference product in patients with active rheumatoid arthritis: data from randomised double-blind and open-label extension studiesMark C Genovese, Herbert Kellner, Yasumasa Arai, et al.
Pageof 197